An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
metabolic phenotype correlation to clinical endpoints
To correlate the metabolic phenotype obtained from histopathological diagnosis with the clinical endpoints of time to tumor progression and overall survival during the 5 years of patient follow-up
at end of follow-up period- between days 1-14
No
Elizabeth Maher, MD, PhD
Principal Investigator
University of Texas
United States: Institutional Review Board
SCCC-03F09
NCT01668082
May 2010
July 2015
Name | Location |
---|---|
University of Texas Southwestern | Dallas, Texas 75390 |